This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Hospira Infusion Pumps Ranked Top Devices In New KLAS Smart Pumps 2012 Report

Stocks in this article: HSP

LAKE FOREST, Ill., April 12, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced its Symbiq and LifeCare PCA infusion pumps have been ranked as the top devices in their categories in the KLAS report, Smart Pumps 2012: Wireless Technology and EMR Integration Report . Hospira was also recognized as the "early leader" in electronic medical record (EMR) integration with infusion pumps. The rankings are based on data from customer surveys of North American hospital and clinic executives, administrators, physicians, nurses, clinicians, and other directors and managers interacting with healthcare equipment and infrastructure solutions. 

"Hospira is proud to be recognized for its advances in smart pump technology, patient safety, medication delivery and caregiver efficiency," said Thomas Moore, president, United States, Hospira. "As the leader in infusion technologies and I.V. clinical integration (I.V.C.I), Hospira focuses on delivering quality technology and services to our customers across our entire smart pump offering."

The Symbiq infusion device, considered the leader in its market segment, scored the highest overall performance rating (81.7)[1] for large volume pumps (LVPs). LifeCare PCA, also deemed a leading pump, scored the highest overall performance rating for patient-controlled analgesia pumps (PCAs) with a score of 81.1.

The Symbiq infusion system is a technologically advanced infusion device with clinician-friendly features designed to help improve workflow and decrease medication errors. With  Hospira MedNet™ safety software built into the device, Symbiq was the first general infusion system developed to provide additional medication-error protection by requiring users to select a drug library entry from the safety software for all drug delivery programs. Due to its highly sophisticated technology, Symbiq is one of the first devices to achieve I.V.C.I. of infusion pumps with EMRs.

To learn how WellSpan Health is using I.V.C.I. with full auto-programming technology to advance its focus on providing exceptional care, view this video: I.V. Clinical Integration: WellSpan Health.

The Symbiq infusion device was the only smart pump with a significant score increase in the past year, as all measured areas saw increased satisfaction. The KLAS smart pump 2012 report praised Symbiq for newer, more advanced technology. Symbiq infusion pumps have the highest-reported safety software drug library compliance among LVPs, at 93 percent.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs